target audience: TECH BUYER Publication date: Mar 2024 - Document type: IDC Perspective - Doc Document number: # US51965024
Drivers and Roadblocks for GenAI Adoption in the Life Science Industry
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Perspective reviews some of the key drivers and roadblocks for generative AI (GenAI) adoption in the life science industry and provides advice to technology buyers from the life science industry to help them make strategic decisions on their life science GenAI road map.
"While there are several drivers and roadblocks impacting the adoption of GenAI, the reality is that GenAI will disrupt and transform the life science industry. Fast adopters (that build in the necessary guardrails to ensure patient safety and regulatory compliance) will become leaders. GenAI has brought about the democratization of AI, and it will be incumbent upon executive leadership to make this technology accessible to all of its stakeholders, including employees, patients, and providers; build GenAI expertise within the organization; and drive an openness to adopt and adapt to the GenAI revolution that is reshaping the life science industry," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.